TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+25.92%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$269M
AUM Growth
+$269M
(-18%)
Cap. Flow
-$73.8M
Cap. Flow
% of AUM
-27.47%
Top 10 Holdings %
Top 10 Hldgs %
55.73%
Holding
84
New
36
Increased
10
Reduced
12
Closed
25
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$21.1M |
| 2 |
Medtronic
MDT
|
$14.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$8.66M |
| 4 |
Legend Biotech
LEGN
|
$8.06M |
| 5 |
DexCom
DXCM
|
$6.66M |
Top Sells
| 1 |
Abbott
ABT
|
$17.7M |
| 2 |
Tandem Diabetes Care
TNDM
|
$17M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$16.3M |
| 4 |
ARK Innovation ETF
ARKK
|
$14.1M |
| 5 |
Sarepta Therapeutics
SRPT
|
$12.3M |
Sector Composition
| 1 | Healthcare | 99.2% |
| 2 | Financials | 0.24% |
| 3 | Industrials | 0.21% |
| 4 | Energy | 0.12% |
| 5 | Technology | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $25.5M | 9.48% | 54,369 +9,921 | +22% | +$4.65M |
|
|
2
Johnson & Johnson
JNJ
$427B
| $21.1M | 7.83% | +127,362 | New | +$21.1M |
|
|
AVDL
3
Avadel Pharmaceuticals
AVDL
$1.43B
| $17.1M | 6.37% | 1,039,474 -287,623 | -22% | -$4.74M |
|
4
West Pharmaceutical
WST
$17.8B
| $15.5M | 5.77% | 40,558 -26,272 | -39% | -$10M |
|
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $14.8M | 5.51% | 20,644 -22,745 | -52% | -$16.3M |
|
6
Axsome Therapeutics
AXSM
$6.05B
| $14.4M | 5.34% | 200,080 +50,875 | +34% | +$3.66M |
|
|
7
Medtronic
MDT
$119B
| $14.2M | 5.26% | +160,660 | New | +$14.2M |
|
|
RETA
8
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $9.82M | 3.65% | 96,274 +29,068 | +43% | +$2.96M |
|
|
CTLT
9
DELISTED
CATALENT, INC.
CTLT
| $8.72M | 3.24% | 200,997 -24,402 | -11% | -$1.06M |
|
|
10
Vertex Pharmaceuticals
VRTX
$100B
| $8.66M | 3.22% | +24,597 | New | +$8.66M |
|
11
Teva Pharmaceuticals
TEVA
$21.1B
| $8.33M | 3.09% | 1,105,770 +93,397 | +9% | +$703K |
|
|
12
Legend Biotech
LEGN
$6.41B
| $8.06M | 3% | +116,768 | New | +$8.06M |
|
13
X4 Pharmaceuticals
XFOR
$84.2M
| $7.95M | 2.96% | 4,099,943 +221,459 | +6% | +$430K |
|
14
Illumina
ILMN
$15.8B
| $7.66M | 2.85% | 40,832 -21,987 | -35% | -$4.12M |
|
|
15
DexCom
DXCM
$29.5B
| $6.66M | 2.47% | +51,798 | New | +$6.66M |
|
|
NARI
16
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $6.6M | 2.45% | +113,441 | New | +$6.6M |
|
|
SILK
17
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $6.45M | 2.4% | +198,532 | New | +$6.45M |
|
18
Madrigal Pharmaceuticals
MDGL
$9.76B
| $6.01M | 2.23% | 26,010 +12,165 | +88% | +$2.81M |
|
19
Stevanato
STVN
$6.28B
| $5.71M | 2.12% | 176,359 -101,108 | -36% | -$3.27M |
|
|
IMGN
20
DELISTED
Immunogen Inc
IMGN
| $5.62M | 2.09% | +297,807 | New | +$5.62M |
|
21
Praxis Precision Medicines
PRAX
$958M
| $5.62M | 2.09% | 4,884,621 +2,396,267 | +96% | +$2.76M |
|
22
Alnylam Pharmaceuticals
ALNY
$58.5B
| $5.6M | 2.08% | +29,506 | New | +$5.6M |
|
|
ALPN
23
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $3.41M | 1.27% | +331,992 | New | +$3.41M |
|
|
VRNA
24
Verona Pharma
VRNA
$9.16B
| $3.2M | 1.19% | 151,194 +53,380 | +55% | +$1.13M |
|
25
89bio
ETNB
$1.34B
| $3.14M | 1.17% | 165,897 +8,672 | +6% | +$164K |
|